FIGURE 4.

Validation of prognostic value of risk scores in CGGA‐693 and CGGA‐325 cohorts. A and G, The relationship between risk score and glioma patients’ prognosis in CGGA‐693 and CGGA‐325, respectively. B and H, Effects of distinct risk score in different glioma grades according to WHO on the patients’ survival. C and I, Validation of the predictive value of risk score in the aspect of 1 year AUC, 3 years AUC and 5 years AUC via ROC curve analysis in CGGA‐693 and CGGA‐325 cohorts, respectively. D and J, Correlations between risk score and glioma grades in CGGA‐693 and CGGA‐325, respectively. E and K, Correlation between risk score and IDH mutation in CGGA‐693 and CGGA‐325, respectively. F and L, Correlation between risk score and 1p/19q co‐deletion in CGGA‐693 and CGGA‐325, respectively